CervoMed CRVO
NASDAQ CRVO
$3.02 +0.09 (+3.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

CervoMed (CRVO) Gross Margin (2011 - 2013)

Updated

CervoMed's Gross Margin was 100.00% in Q2 2013, up 0.59 percentage points from 99.41% a year earlier.

Analysis

CervoMed (CRVO) Gross Margin (2011 - 2013) Analysis & Trends

For FY2012, Gross Margin at CervoMed came in at 37.04%, up 341.72 percentage points from FY2011.

  • In earlier years, Gross Margin was -304.68% in FY2011 (+118.83 pp) and -423.51% in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 85.78%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 68.19%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 74.74%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 73.54%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 78.02%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 83.60%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 72.04%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 79.76%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 72.78%
10 CervoMed 30.02 Mn 30.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2013 100.00%
Sep 30, 2012 99.41%
Jun 30, 2012 99.41%
Mar 31, 2012 -43.22%
Dec 31, 2011 -541.57%
Sep 30, 2011 -1.44%
API Access

CervoMed Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=CRVO&period=max&api_key=YOUR_API_KEY